<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2d1 20170631//EN" "JATS-journalpublishing1.dtd">
<article xlink="http://www.w3.org/1999/xlink" dtd-version="1.0" article-type="healthcare" lang="en"><front><journal-meta><journal-id journal-id-type="publisher">IJCRR</journal-id><journal-id journal-id-type="nlm-ta">I Journ Cur Res Re</journal-id><journal-title-group><journal-title>International Journal of Current Research and Review</journal-title><abbrev-journal-title abbrev-type="pubmed">I Journ Cur Res Re</abbrev-journal-title></journal-title-group><issn pub-type="ppub">2231-2196</issn><issn pub-type="opub">0975-5241</issn><publisher><publisher-name>Radiance Research Academy</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">4192</article-id><article-id pub-id-type="doi"/><article-id pub-id-type="doi-url">http://dx.doi.org/10.31782/IJCRR.2021.132018</article-id><article-categories><subj-group subj-group-type="heading"><subject>Healthcare</subject></subj-group></article-categories><title-group><article-title>Comparative Evaluation of Antifungal Effect of Origanum Oil Solution and Povidone Iodine Aqueous Solution on Scleral Resin:__ampersandsignnbsp;An In-Vitro Study&#13;
</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>S.</surname><given-names>Pande Samidha</given-names></name></contrib><contrib contrib-type="author"><name><surname>Seema</surname><given-names>Sathe Kambala</given-names></name></contrib><contrib contrib-type="author"><name><surname>Surekha</surname><given-names>Godbole Dubey</given-names></name></contrib><contrib contrib-type="author"><name><surname>P.</surname><given-names>Revankar Ramnath</given-names></name></contrib></contrib-group><pub-date pub-type="ppub"><day>24</day><month>10</month><year>2021</year></pub-date><volume>0)</volume><issue/><fpage>174</fpage><lpage>178</lpage><permissions><copyright-statement>This article is copyright of Popeye Publishing, 2009</copyright-statement><copyright-year>2009</copyright-year><license license-type="open-access" href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution (CC BY 4.0) Licence. You may share and adapt the material, but must give appropriate credit to the source, provide a link to the licence, and indicate if changes were made.</license-p></license></permissions><abstract><p>Aim: To compare and evaluate the antifungal effect of origanum oil and povidone-iodine aqueous solution on scleral resin. Introduction: Ocular prosthesis being a part of maxillofacial prosthodontics aims to restore and repair the ophthalmic cavity. An important prerequisite for a prosthesis is the eradication of plaque accumulation due to bacteria. To neglect probable infections in the patient__ampersandsignrsquo;s ophthalmic cavity a naturally available antifungal agent was tested in this study. Methods and Material: In this study, 40 custom made scleral resin disks (20 in each group) immersed in 2 different solutions were studied for their antifungal activity. The evaluation of this property was done by calculating the zone of inhibition around the disks propelled in the specific agar media. Statistical Analysis: Descriptive and analytical statistics were done. The data is represented in mean and standard deviation. The normality of continuous data was analysed by the Shapiro-Wilk test. As the data followed a normal distribution, parametric tests were used to analyse the data. The independent sample t-test and paired sample t-test were used to check to mean differences. The level of significance was kept at p__ampersandsignlt;0.05. The software used wasSPSS (StatisticalPackagefor Social Sciences) Version 24.0 (IBM Corporation, Chicago, USA) Results: The antifungal efficacy of the origanum oil solution was found to be significantly higher than the povidone-iodine solution. Conclusion: This study concluded that origanumoil is a potent antifungal against C. Albicans. This encourages the researcher to assess the effectiveness of O. vulgare oil in other forms of systemic and superficial fungal infections as well as to investigate its broad-spectrum outcome against other pathogenic manifestations which also include malignancies.&#13;
</p></abstract><kwd-group><kwd>Ocular prosthesis</kwd><kwd> Antifungal</kwd><kwd> Origanum oil</kwd><kwd> C.Albicans</kwd><kwd> SDA</kwd><kwd> Maxillofacial</kwd><kwd> Prosthetics</kwd></kwd-group></article-meta></front></article>
